Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Zantac’s Original Maker Halts Shipping on Carcinogen Concern (1)

Sept. 25, 2019, 6:17 PMUpdated: Sept. 25, 2019, 10:19 PM

GlaxoSmithKline Plc, the original branded maker of Zantac, halted global distribution of the popular stomach medicine, adding momentum to actions aimed at stopping access to drugs that are tainted with a potential human carcinogen.

Glaxo will also recall the drug in India, where it’s known as Zinetac, and Hong Kong. The recalled medicine is made with an active ingredient from two India-based suppliers, Dr. Reddy’s Laboratories Ltd. and Saraca Laboratories Ltd., Kristen Neese, a spokeswoman for Glaxo, said in an email Sept. 25.

Dr. Reddy’s, one of India’s largest generic drugmakers, is FDA-approved to sell its ...